Wednesday, October 19, 2011 1:03:42 PM
Chembio Diagnostics reported that its Dual Path Platform, DPP, technology has been or will soon be granted patent protection in a number of major markets including Japan, with the Company recently being notified that the DPP? patent has been allowed in Japan and will therefore be issued there shortly. The anticipated issuance in Japan, combined with previous DPP? patent issuances in the United States in 2007, and in the United Kingdom, China, Indonesia, Singapore, Malaysia, Australia, Eurasia, and Mexico more recently provides Chembio with an increasingly global patent protection for DPP? products covering many large and emerging markets. Chembio believes this is important in connection with possible collaborations, distribution agreements, and/or other commercial or strategic transactions, as well as to investors. Furthermore, to the extent DPP? patent applications pending in Europe, South America, Korea, and other jurisdictions result in additional patent DPP? issuances to Chembio, the global footprint of this patent protection would be even further extended.
Recent CEMI News
- Life Science Outsourcing, Inc. Welcomes Neil A. Goldman as Chief Financial Officer • PR Newswire (US) • 10/17/2023 09:00:00 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM